Characterization of KIF11 as a novel prognostic biomarker and therapeutic target for oral cancer
Oral cancer has a high mortality rate, and its incidence is increasing gradually worldwide. As the effectiveness of standard treatments is still limited, the development of new therapeutic strategies is eagerly awaited. Kinesin family member 11 (KIF11) is a motor protein required for establishing a...
Gespeichert in:
| Veröffentlicht in: | International journal of oncology 2018-01, Vol.52 (1), p.155-165 |
|---|---|
| Hauptverfasser: | , , , , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 165 |
|---|---|
| container_issue | 1 |
| container_start_page | 155 |
| container_title | International journal of oncology |
| container_volume | 52 |
| creator | Daigo, Kayo Takano, Atsushi Thang, Phung Manh Yoshitake, Yoshihiro Shinohara, Masanori Tohnai, Iwau Murakami, Yoshinori Maegawa, Jiro Daigo, Yataro |
| description | Oral cancer has a high mortality rate, and its incidence is increasing gradually worldwide. As the effectiveness of standard treatments is still limited, the development of new therapeutic strategies is eagerly awaited. Kinesin family member 11 (KIF11) is a motor protein required for establishing a bipolar spindle in cell division. The role of KIF11 in oral cancer is unclear. Therefore, the present study aimed to assess the role of KIF11 in oral cancer and evaluate its role as a prognostic biomarker and therapeutic target for treating oral cancer. Immunohistochemical analysis demonstrated that KIF11 was expressed in 64 of 99 (64.6%) oral cancer tissues but not in healthy oral epithelia. Strong KIF11 expression was significantly associated with poor prognosis among oral cancer patients (P=0.034), and multivariate analysis confirmed its independent prognostic value. In addition, inhibition of KIF11 expression by transfection of siRNAs into oral cancer cells or treatment of cells with a KIF11 inhibitor significantly suppressed cell proliferation, probably through G2/M arrest and subsequent induction of apoptosis. These results suggest that KIF11 could be a potential prognostic biomarker and therapeutic target for oral cancer. |
| doi_str_mv | 10.3892/ijo.2017.4181 |
| format | Article |
| fullrecord | <record><control><sourceid>gale_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_5743338</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A526316325</galeid><sourcerecordid>A526316325</sourcerecordid><originalsourceid>FETCH-LOGICAL-c579t-1240203f1284f7d554034ca9845ef5b2e954ec7124f06dfb0957bc77a93ec7733</originalsourceid><addsrcrecordid>eNptks9rFDEUxwdRbK0evUpA8DZrfk4mF6EsVksLXvQcM5mXnayzyZpkC_WvN0Nr7ULJIeG9z_vyTfJtmrcEr1iv6Ee_jSuKiVxx0pNnzSmRirSUU_a8njFRbceZOmle5bzFmAqBycvmhCpChOi70-bnejLJ2ALJ_zHFx4CiQ1eXF4Qgk5FBId7AjPYpbkLMxVs0-Lgz6RckZMKIygTJ7OGwdIpJGyjIxYRiMjOyJlhIr5sXzswZ3tzvZ82Pi8_f11_b629fLtfn160VUpWWUI4pZo7Qnjs5CsEx49aongtwYqCgBAcrK-ZwN7oBKyEHK6VRrJYlY2fNpzvd_WHYwWghlGpC75Ovdm91NF4fd4Kf9CbeaCE5Y6yvAu_vBVL8fYBc9DYeUqieNVGKYEGlJP-pjZlB--BiFbM7n60-F7RjpGNUVGr1BFXXCDtvYwDna_1o4MOjgQnMXKYc58PyI_kYbO9Am2LOCdzDDQnWSyB0DYReAqGXQFT-3eNneaD_JYD9Bcyvr0g</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1991052771</pqid></control><display><type>article</type><title>Characterization of KIF11 as a novel prognostic biomarker and therapeutic target for oral cancer</title><source>Spandidos Publications Journals</source><source>Alma/SFX Local Collection</source><source>EZB Electronic Journals Library</source><creator>Daigo, Kayo ; Takano, Atsushi ; Thang, Phung Manh ; Yoshitake, Yoshihiro ; Shinohara, Masanori ; Tohnai, Iwau ; Murakami, Yoshinori ; Maegawa, Jiro ; Daigo, Yataro</creator><creatorcontrib>Daigo, Kayo ; Takano, Atsushi ; Thang, Phung Manh ; Yoshitake, Yoshihiro ; Shinohara, Masanori ; Tohnai, Iwau ; Murakami, Yoshinori ; Maegawa, Jiro ; Daigo, Yataro</creatorcontrib><description>Oral cancer has a high mortality rate, and its incidence is increasing gradually worldwide. As the effectiveness of standard treatments is still limited, the development of new therapeutic strategies is eagerly awaited. Kinesin family member 11 (KIF11) is a motor protein required for establishing a bipolar spindle in cell division. The role of KIF11 in oral cancer is unclear. Therefore, the present study aimed to assess the role of KIF11 in oral cancer and evaluate its role as a prognostic biomarker and therapeutic target for treating oral cancer. Immunohistochemical analysis demonstrated that KIF11 was expressed in 64 of 99 (64.6%) oral cancer tissues but not in healthy oral epithelia. Strong KIF11 expression was significantly associated with poor prognosis among oral cancer patients (P=0.034), and multivariate analysis confirmed its independent prognostic value. In addition, inhibition of KIF11 expression by transfection of siRNAs into oral cancer cells or treatment of cells with a KIF11 inhibitor significantly suppressed cell proliferation, probably through G2/M arrest and subsequent induction of apoptosis. These results suggest that KIF11 could be a potential prognostic biomarker and therapeutic target for oral cancer.</description><identifier>ISSN: 1019-6439</identifier><identifier>EISSN: 1791-2423</identifier><identifier>DOI: 10.3892/ijo.2017.4181</identifier><identifier>PMID: 29115586</identifier><language>eng</language><publisher>Greece: Spandidos Publications</publisher><subject>Cancer therapies ; Care and treatment ; Cell division ; Cellular proteins ; Chemotherapy ; Development and progression ; Gene expression ; Genetic aspects ; Health aspects ; Innovations ; Medical prognosis ; Molecular targeted therapy ; Mouth cancer ; Multivariate analysis ; Oral cancer ; Proteins ; Radiation therapy ; Surgery</subject><ispartof>International journal of oncology, 2018-01, Vol.52 (1), p.155-165</ispartof><rights>COPYRIGHT 2018 Spandidos Publications</rights><rights>Copyright Spandidos Publications UK Ltd. 2018</rights><rights>Copyright: © Daigo et al. 2018</rights><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c579t-1240203f1284f7d554034ca9845ef5b2e954ec7124f06dfb0957bc77a93ec7733</citedby><cites>FETCH-LOGICAL-c579t-1240203f1284f7d554034ca9845ef5b2e954ec7124f06dfb0957bc77a93ec7733</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>230,314,780,784,885,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/29115586$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Daigo, Kayo</creatorcontrib><creatorcontrib>Takano, Atsushi</creatorcontrib><creatorcontrib>Thang, Phung Manh</creatorcontrib><creatorcontrib>Yoshitake, Yoshihiro</creatorcontrib><creatorcontrib>Shinohara, Masanori</creatorcontrib><creatorcontrib>Tohnai, Iwau</creatorcontrib><creatorcontrib>Murakami, Yoshinori</creatorcontrib><creatorcontrib>Maegawa, Jiro</creatorcontrib><creatorcontrib>Daigo, Yataro</creatorcontrib><title>Characterization of KIF11 as a novel prognostic biomarker and therapeutic target for oral cancer</title><title>International journal of oncology</title><addtitle>Int J Oncol</addtitle><description>Oral cancer has a high mortality rate, and its incidence is increasing gradually worldwide. As the effectiveness of standard treatments is still limited, the development of new therapeutic strategies is eagerly awaited. Kinesin family member 11 (KIF11) is a motor protein required for establishing a bipolar spindle in cell division. The role of KIF11 in oral cancer is unclear. Therefore, the present study aimed to assess the role of KIF11 in oral cancer and evaluate its role as a prognostic biomarker and therapeutic target for treating oral cancer. Immunohistochemical analysis demonstrated that KIF11 was expressed in 64 of 99 (64.6%) oral cancer tissues but not in healthy oral epithelia. Strong KIF11 expression was significantly associated with poor prognosis among oral cancer patients (P=0.034), and multivariate analysis confirmed its independent prognostic value. In addition, inhibition of KIF11 expression by transfection of siRNAs into oral cancer cells or treatment of cells with a KIF11 inhibitor significantly suppressed cell proliferation, probably through G2/M arrest and subsequent induction of apoptosis. These results suggest that KIF11 could be a potential prognostic biomarker and therapeutic target for oral cancer.</description><subject>Cancer therapies</subject><subject>Care and treatment</subject><subject>Cell division</subject><subject>Cellular proteins</subject><subject>Chemotherapy</subject><subject>Development and progression</subject><subject>Gene expression</subject><subject>Genetic aspects</subject><subject>Health aspects</subject><subject>Innovations</subject><subject>Medical prognosis</subject><subject>Molecular targeted therapy</subject><subject>Mouth cancer</subject><subject>Multivariate analysis</subject><subject>Oral cancer</subject><subject>Proteins</subject><subject>Radiation therapy</subject><subject>Surgery</subject><issn>1019-6439</issn><issn>1791-2423</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2018</creationdate><recordtype>article</recordtype><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><recordid>eNptks9rFDEUxwdRbK0evUpA8DZrfk4mF6EsVksLXvQcM5mXnayzyZpkC_WvN0Nr7ULJIeG9z_vyTfJtmrcEr1iv6Ee_jSuKiVxx0pNnzSmRirSUU_a8njFRbceZOmle5bzFmAqBycvmhCpChOi70-bnejLJ2ALJ_zHFx4CiQ1eXF4Qgk5FBId7AjPYpbkLMxVs0-Lgz6RckZMKIygTJ7OGwdIpJGyjIxYRiMjOyJlhIr5sXzswZ3tzvZ82Pi8_f11_b629fLtfn160VUpWWUI4pZo7Qnjs5CsEx49aongtwYqCgBAcrK-ZwN7oBKyEHK6VRrJYlY2fNpzvd_WHYwWghlGpC75Ovdm91NF4fd4Kf9CbeaCE5Y6yvAu_vBVL8fYBc9DYeUqieNVGKYEGlJP-pjZlB--BiFbM7n60-F7RjpGNUVGr1BFXXCDtvYwDna_1o4MOjgQnMXKYc58PyI_kYbO9Am2LOCdzDDQnWSyB0DYReAqGXQFT-3eNneaD_JYD9Bcyvr0g</recordid><startdate>20180101</startdate><enddate>20180101</enddate><creator>Daigo, Kayo</creator><creator>Takano, Atsushi</creator><creator>Thang, Phung Manh</creator><creator>Yoshitake, Yoshihiro</creator><creator>Shinohara, Masanori</creator><creator>Tohnai, Iwau</creator><creator>Murakami, Yoshinori</creator><creator>Maegawa, Jiro</creator><creator>Daigo, Yataro</creator><general>Spandidos Publications</general><general>Spandidos Publications UK Ltd</general><general>D.A. Spandidos</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7RV</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AN0</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>K9.</scope><scope>KB0</scope><scope>M0S</scope><scope>M1P</scope><scope>NAPCQ</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>5PM</scope></search><sort><creationdate>20180101</creationdate><title>Characterization of KIF11 as a novel prognostic biomarker and therapeutic target for oral cancer</title><author>Daigo, Kayo ; Takano, Atsushi ; Thang, Phung Manh ; Yoshitake, Yoshihiro ; Shinohara, Masanori ; Tohnai, Iwau ; Murakami, Yoshinori ; Maegawa, Jiro ; Daigo, Yataro</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c579t-1240203f1284f7d554034ca9845ef5b2e954ec7124f06dfb0957bc77a93ec7733</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2018</creationdate><topic>Cancer therapies</topic><topic>Care and treatment</topic><topic>Cell division</topic><topic>Cellular proteins</topic><topic>Chemotherapy</topic><topic>Development and progression</topic><topic>Gene expression</topic><topic>Genetic aspects</topic><topic>Health aspects</topic><topic>Innovations</topic><topic>Medical prognosis</topic><topic>Molecular targeted therapy</topic><topic>Mouth cancer</topic><topic>Multivariate analysis</topic><topic>Oral cancer</topic><topic>Proteins</topic><topic>Radiation therapy</topic><topic>Surgery</topic><toplevel>online_resources</toplevel><creatorcontrib>Daigo, Kayo</creatorcontrib><creatorcontrib>Takano, Atsushi</creatorcontrib><creatorcontrib>Thang, Phung Manh</creatorcontrib><creatorcontrib>Yoshitake, Yoshihiro</creatorcontrib><creatorcontrib>Shinohara, Masanori</creatorcontrib><creatorcontrib>Tohnai, Iwau</creatorcontrib><creatorcontrib>Murakami, Yoshinori</creatorcontrib><creatorcontrib>Maegawa, Jiro</creatorcontrib><creatorcontrib>Daigo, Yataro</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Nursing & Allied Health Database (ProQuest)</collection><collection>ProQuest Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central UK/Ireland</collection><collection>British Nursing Database</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Nursing & Allied Health Database (Alumni Edition)</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>PML(ProQuest Medical Library)</collection><collection>Nursing & Allied Health Premium</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>International journal of oncology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Daigo, Kayo</au><au>Takano, Atsushi</au><au>Thang, Phung Manh</au><au>Yoshitake, Yoshihiro</au><au>Shinohara, Masanori</au><au>Tohnai, Iwau</au><au>Murakami, Yoshinori</au><au>Maegawa, Jiro</au><au>Daigo, Yataro</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Characterization of KIF11 as a novel prognostic biomarker and therapeutic target for oral cancer</atitle><jtitle>International journal of oncology</jtitle><addtitle>Int J Oncol</addtitle><date>2018-01-01</date><risdate>2018</risdate><volume>52</volume><issue>1</issue><spage>155</spage><epage>165</epage><pages>155-165</pages><issn>1019-6439</issn><eissn>1791-2423</eissn><abstract>Oral cancer has a high mortality rate, and its incidence is increasing gradually worldwide. As the effectiveness of standard treatments is still limited, the development of new therapeutic strategies is eagerly awaited. Kinesin family member 11 (KIF11) is a motor protein required for establishing a bipolar spindle in cell division. The role of KIF11 in oral cancer is unclear. Therefore, the present study aimed to assess the role of KIF11 in oral cancer and evaluate its role as a prognostic biomarker and therapeutic target for treating oral cancer. Immunohistochemical analysis demonstrated that KIF11 was expressed in 64 of 99 (64.6%) oral cancer tissues but not in healthy oral epithelia. Strong KIF11 expression was significantly associated with poor prognosis among oral cancer patients (P=0.034), and multivariate analysis confirmed its independent prognostic value. In addition, inhibition of KIF11 expression by transfection of siRNAs into oral cancer cells or treatment of cells with a KIF11 inhibitor significantly suppressed cell proliferation, probably through G2/M arrest and subsequent induction of apoptosis. These results suggest that KIF11 could be a potential prognostic biomarker and therapeutic target for oral cancer.</abstract><cop>Greece</cop><pub>Spandidos Publications</pub><pmid>29115586</pmid><doi>10.3892/ijo.2017.4181</doi><tpages>11</tpages><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 1019-6439 |
| ispartof | International journal of oncology, 2018-01, Vol.52 (1), p.155-165 |
| issn | 1019-6439 1791-2423 |
| language | eng |
| recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_5743338 |
| source | Spandidos Publications Journals; Alma/SFX Local Collection; EZB Electronic Journals Library |
| subjects | Cancer therapies Care and treatment Cell division Cellular proteins Chemotherapy Development and progression Gene expression Genetic aspects Health aspects Innovations Medical prognosis Molecular targeted therapy Mouth cancer Multivariate analysis Oral cancer Proteins Radiation therapy Surgery |
| title | Characterization of KIF11 as a novel prognostic biomarker and therapeutic target for oral cancer |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-25T08%3A52%3A04IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Characterization%20of%20KIF11%20as%20a%20novel%20prognostic%20biomarker%20and%20therapeutic%20target%20for%20oral%20cancer&rft.jtitle=International%20journal%20of%20oncology&rft.au=Daigo,%20Kayo&rft.date=2018-01-01&rft.volume=52&rft.issue=1&rft.spage=155&rft.epage=165&rft.pages=155-165&rft.issn=1019-6439&rft.eissn=1791-2423&rft_id=info:doi/10.3892/ijo.2017.4181&rft_dat=%3Cgale_pubme%3EA526316325%3C/gale_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1991052771&rft_id=info:pmid/29115586&rft_galeid=A526316325&rfr_iscdi=true |